Trial of cord blood aims to prevent cerebral palsy
Exciting new research using stem cells from umbilical cord blood in the treatment and prevention of cerebral palsy in new borns is being planned to commence in Melbourne. Click below to read the full story:
Trial of sibling cord blood aims to prove safety and lead to cerebral palsy treatments.
Australia’s first clinical trial of stem cell infusion from cord blood as a possible treatment for cerebral palsy (CP) is commencing in Melbourne. The safety trial, led by the Murdoch Childrens Research Institute (MCRI), will recruit patients nationally and take place at The Royal Children’s Hospital. Expected to take two years, the study is being funded by the Cerebral Palsy Alliance Research Foundation and Cell Care, Australia’s largest private cord blood bank. It is the first step in a promising process that eventually aims to find out whether cord blood infusion is both safe and efficacious for children with the condition.
Entry into the Study
In order to be screened for eligibility to the study, the following criteria must be met:
If these criteria are met, individuals can then be assessed for eligibility to the study.
If you have a child with cerebral palsy and have stored cord blood from a subsequent sibling, please contact the Study Coordinator via email: email@example.com or
phone (03) 9936 6756.
If you have a child with cerebral palsy and are pregnant, you may be eligible for Cell Care’s free Cerebral Palsy Cord Blood Collection Program.
Contact Cell Care for more information via email: firstname.lastname@example.org or
phone: 1800 071 075.